James D Rodgers,Stacey Shepard,Argyrios G Arvanitis,Haisheng Wang,Louis Storace,Beverly Folmer,Wenyu Zhu,Joseph Glenn,Lixin Shao
申请号：
US14250843
公开号：
US09334274B2
申请日:
2014.04.11
申请国别(地区):
US
年份:
2016
代理人:
摘要：
The present invention relates to N-(hetero)aryl-pyrrolidine derivatives of Formula I:which are JAK inhibitors, such as selective JAK1 inhibitors, useful in the treatment of JAK-associated diseases including, for example, inflammatory and autoimmune disorders, as well as cancer.
